Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Compugen Ltd

Clinical trials sponsored by Compugen Ltd, explained in plain language.

Compugen Ltd CGEN NASDAQ

A clinical-stage biotech company developing cancer immunotherapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Completed 1

Experimental COM902 drug shows promise in early cancer trial

Disease control Completed

This early-phase study tested an experimental drug called COM902, alone or with other drugs, in 94 people with advanced cancers like ovarian, lung, and colon cancer. The main goal was to check safety and find the right dose. Researchers also looked for early signs that the drug m…

Phase: PHASE1 • Sponsor: Compugen Ltd • Aim: Disease control

Last updated Aug 14, 2026 00:00 UTC